Clinical Trial Update: Basal Insulin for Type 2 Diabetes Patients Treated in Outpatient Clalit Clinics

View source ↗

Summary

A Sanofi-sponsored trial evaluating basal insulin in outpatient Type 2 diabetes patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Basal insulin (basal insulin)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes | Status: COMPLETED